Health
Researchers develop promising new drug candidates to treat ALS – Drug Target Review
Scientists have shown that a Selenium-based drug-molecule called ebselen and other novel compounds can delay ALS onset in mouse models.
Posted: 2 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
Scientists have shown that a Selenium-based drug-molecule called ebselen and other novel compounds can delay ALS onset in mouse models.
Scientists report that they have taken a significant step forward in the search to find effective new drugs for the treatment of Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease.
Researchers from the University of Liverpool, UK, and University of Nagoya, Ja…
-
Noosa News22 hours agoRallies under way as nationwide support for Palestine surges
-
General24 hours agoNRL live updates: Newcastle Knights vs Brisbane Broncos, Wests Tigers vs North Queensland Cowboys — blog, scores and stats
-
General19 hours agoThousands flood cities demanding action on Palestine
-
Noosa News22 hours agoHusband charged after beloved Brisbane nurse Carra Luke allegedly stabbed to death in Taigum home